SEE ALSO...
HLA Antibodies
Empty Table Header | Product Name | CATALOG # | ISOTYPE | EPITOPE | APPLICATIONS | Species | Citations | RATING |
---|---|---|---|---|---|---|---|---|
HLA class I Antibody (HP-1F7) | sc-69892 | mouse IgG1 κ | (h) | WB, IP, FCM | h | 7 | ||
HLA class I Antibody (YTH862.2) | sc-59206 | rat IgG2b | (h) | WB, IP, IF, FCM | h | 2 | ||
HLA class I Antibody (MEM-147) | sc-51672 | mouse IgG1 | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-A Antibody (B-11) | sc-390473 | mouse IgM κ | 26-45 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 3 | ||
HLA-A Antibody (C-6) | sc-365485 | mouse IgG2b κ | 61-93 (h) | WB, IP, IF, IHC(P), ELISA | h | 9 | ||
HLA-A/B/C Antibody (LY5.1) | sc-52810 | mouse IgG1 κ | (h) | WB, IP, IF | h | 8 | ||
HLA-A/B/C Antibody (3F10) | sc-65288 | mouse IgG2a | (h) | IP, IF, FCM | h | 1 | ||
HLA-A2 Antibody (BB7.2) | sc-32236 | mouse IgG2b κ | (h) | FCM | h | 12 | ||
HLA-B/C Antibody (A-3) | sc-166668 | mouse IgG1 κ | 126-145 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
HLA-B/C Antibody (A-4) | sc-166544 | mouse IgG2a κ | N-terminal (h) | WB, IP, IF, ELISA | h | new | ||
HLA-B7 Antibody (BB7.1) | sc-53304 | mouse IgG1 κ | (h) | FCM | h | 2 | ||
HLA-B27 Antibody (EP-4) | sc-59233 | mouse IgM | (h) | IF | h | new | ||
HLA-C Antibody (H-5) | sc-166134 | mouse IgG3 κ | 91-123 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-C Antibody (C-8) | sc-166088 | mouse IgG1 κ | 91-123 (h) | WB, IP, IF, ELISA | h | 2 | ||
HLA-C Antibody (D-9) | sc-166057 | mouse IgG1 κ | 91-123 (h) | WB, IP, IF, ELISA | h | new | ||
HLA-D/DR/DQ Antibody (35) | sc-53305 | mouse IgG3 κ | (m) | IP, IF, FCM | h | 1 | ||
HLA-DM Antibody (MaP.DM1) | sc-32248 | mouse IgG1 κ | (h) | IF, FCM | h | 5 | ||
HLA-DMα Antibody (NB-B33) | sc-134356 | mouse IgG1 κ | 1-262 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DMβ Antibody (E-8) | sc-393548 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DMβ Antibody (DM.K8) | sc-69738 | mouse IgG1 κ | (h) | WB, IP, IF | h | new | ||
HLA-DOα Antibody (C-11) | sc-515446 | mouse IgG1 κ | 83-127 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
HLA-DOβ Antibody (DOB.L1) | sc-69739 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P) | h | 3 | ||
HLA-DP Antibody (G-9) | sc-390694 | mouse IgG2b κ | 69-102 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
HLA-DP Antibody (BRAFB6) | sc-33719 | mouse IgG2b κ | FL (h) | WB, IP, FCM | m, r, h | 6 | ||
HLA-DP Antibody (OX76) | sc-53077 | mouse IgG2a κ | (r) | FCM | m, r | new | ||
HLA-DP Antibody (DP 11.1) | sc-53308 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P), FCM | h | 4 | ||
HLA-DP β1 Antibody (7-RE35) | sc-134357 | mouse IgG2a κ | 1-259 (h) | WB, IP, IF, IHC(P), ELISA | h | 1 | ||
HLA-DP/DR/DQ Antibody (PdV5.2) | sc-130013 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P), functional assay | h | 2 | ||
HLA-DP/DR/DQ Antibody (7.5.10.1) | sc-59238 | mouse IgG2a κ | (h) | IF | h and canine | new | ||
HLA-DPα1 Antibody (NB-A3) | sc-134358 | mouse IgG2a κ | 1-261 (h) | WB, IP, ELISA | h | 1 | ||
HLA-DQ Antibody (TAL 4.1) | sc-53312 | mouse IgG2b κ | (h) | WB, IF, FCM | h | 1 | ||
HLA-DQ Antibody (B-K27) | sc-65320 | mouse IgG2a | (h) | IP, FCM | h | new | ||
HLA-DQ Antibody (HLADQ1) | sc-73390 | mouse IgG1 | (h) | IF, IHC(P), FCM | h | new | ||
HLA-DQ1/3 Antibody (HL-37) | sc-51615 | mouse IgG3 | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-DQ3 Antibody (2HB6) | sc-53310 | mouse IgG1 κ | (h) | IP, FCM | m | new | ||
HLA-DQ3/DQ4/DR4 Antibody (TAL 12.1) | sc-53311 | mouse IgG2b κ | (h) | WB, FCM | h | new | ||
HLA-DQB1 Antibody (Genox 3.53) | sc-53313 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | new | ||
HLA-DQB1 Antibody (IIB3) | sc-59247 | mouse IgG2b κ | IF | h | new | |||
HLA-DR Antibody (520B) | sc-69673 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P), FCM | h | 2 | ||
HLA-DR Antibody (TAL 1B5) | sc-53319 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 34 | ||
HLA-DR Antibody (Bra22) | sc-33718 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 6 | ||
HLA-DR Antibody (L243) | sc-18875 | mouse IgG2a κ | (h) | IF, IHC(P), FCM | h | 17 | ||
HLA-DR Antibody (2.06) | sc-53517 | mouse IgG1 κ | (h) | WB, IP | m, r, h | 1 | ||
HLA-DR Antibody (ML11C11) | sc-73366 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | 1 | ||
HLA-DR Antibody (6A96) | sc-71260 | mouse IgG2b κ | (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR Antibody (Bra20) | sc-33720 | mouse IgG2b κ | FL (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR Antibody (Bra30) | sc-33717 | mouse IgG2a κ | (h) | WB, IP, FCM | m, r, h | new | ||
HLA-DR Antibody (LN3) | sc-59252 | mouse IgG2b κ | (h) | WB, IP, FCM | h | new | ||
HLA-DR Antibody (SPM289) | sc-56545 | mouse IgG2b κ | (h) | WB, IP, IF, IHC(P), FCM | m, r, h | new | ||
HLA-DR Antibody (TAL 15.1) | sc-53317 | mouse IgG2a κ | (h) | WB, IP, FCM | h | new | ||
HLA-DR/DP Antibody (HL-40) | sc-51617 | mouse IgG2a | (h) | WB, IP, FCM | h | 5 | ||
HLA-DR/DP Antibody (HL-38) | sc-51616 | mouse IgG2a | (h) | WB (non-reducing), IP, FCM | h | new | ||
HLA-DR/DP Antibody (MEM-136) | sc-51618 | mouse IgG1 | (h) | WB, IP, FCM | h | 3 | ||
HLA-DR/DP/DQ/DX Antibody (CR3/43) | sc-53302 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 13 | ||
HLA-DRα Antibody (G-7) | sc-55593 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 9 | ||
HLA-DRα Antibody (DA6.147) | sc-53499 | mouse IgG1 κ | (h) | WB, IP, IF | m, r, h | 4 | ||
HLA-DRα Antibody (B-10) | sc-55592 | mouse IgG1 κ | FL (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
HLA-DRβ Antibody (DA2) | sc-53314 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | 3 | ||
HLA-DRβ Antibody (HB10A) | sc-73654 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P) | h | 1 | ||
HLA-DRβ Antibody (TAL 14.1) | sc-53316 | mouse IgG2a κ | (h) | WB, IP, IF, IHC(P), FCM | h | 2 | ||
HLA-DRβ Antibody (TDR 31.1) | sc-53321 | mouse IgG1 κ | (h) | WB, IP, FCM | h | new | ||
HLA-DRβ Antibody (7.3.19.1) | sc-59261 | mouse IgG2b κ | FL (h) | IF | h | new | ||
HLA-DRβ5 Antibody (4D12) | sc-53889 | mouse IgG1 κ | (h) | WB, IP | h | new | ||
HLA-E Antibody (3H2679) | sc-71262 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | h | 3 | ||
HLA-E Antibody (MEM-E/02) | sc-51621 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 7 | ||
HLA-E Antibody (MEM-E/06) | sc-51622 | mouse IgG1 | (h) | WB, IP, IF, IHC(P), FCM | h | 3 | ||
HLA-E Antibody (MEM-E/08) | sc-51624 | mouse IgG1 | (h) | WB, IP, FCM | h | 2 | ||
HLA-E Antibody (4D12) | sc-517455 | mouse IgG1 κ | (h) | WB, IP, IF, FCM | h | new | ||
HLA-F Antibody (201A2H) | sc-517640 | mouse IgG1 κ | (h) | WB | h | new | ||
HLA-F Antibody (201A2J) | sc-517641 | mouse IgG1 κ | (h) | WB | h | new | ||
HLA-G Antibody (4H84) | sc-21799 | mouse IgG1 κ | 61-83 (h) | WB, IP, IF, IHC(P) | m, r, h | 83 | ||
HLA-G Antibody (MEM-G/9) | sc-51678 | mouse IgG1 | (h) | WB, IP, IF, FCM | h | 7 | ||
HLA-G Antibody (MEM-G/1) | sc-51674 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 6 | ||
HLA-G Antibody (MEM-G/2) | sc-51676 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | 2 | ||
HLA-G Antibody (6D463) | sc-71263 | mouse IgG1 | (h) | WB, IP, IF, IHC(P) | h | new | ||
HLA-G Antibody (9-1F10) | sc-53825 | mouse IgG1 | (h) | WB, IP, IF, FCM | h | 1 |
HLA CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
---|---|---|---|---|---|---|---|
HLA-A CRISPR/Cas9 KO Plasmid (h) | sc-400294 | h | Gene Knockout | GFP | 0 | ||
HLA-A HDR Plasmid (h) | sc-400294-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-A Double Nickase Plasmid (h) | sc-400294-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-A Double Nickase Plasmid (h2) | sc-400294-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-B CRISPR/Cas9 KO Plasmid (h) | sc-400627 | h | Gene Knockout | GFP | 0 | ||
HLA-B HDR Plasmid (h) | sc-400627-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-B Double Nickase Plasmid (h) | sc-400627-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-B Double Nickase Plasmid (h2) | sc-400627-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-C CRISPR/Cas9 KO Plasmid (h) | sc-401517 | h | Gene Knockout | GFP | 0 | ||
HLA-C HDR Plasmid (h) | sc-401517-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-C Double Nickase Plasmid (h) | sc-401517-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-C Double Nickase Plasmid (h2) | sc-401517-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα CRISPR/Cas9 KO Plasmid (h) | sc-404576 | h | Gene Knockout | GFP | 0 | ||
HLA-DMα HDR Plasmid (h) | sc-404576-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMα Double Nickase Plasmid (h) | sc-404576-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Double Nickase Plasmid (h2) | sc-404576-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMα CRISPR/Cas9 KO Plasmid (m) | sc-420769 | m | Gene Knockout | GFP | 0 | ||
HLA-DMα HDR Plasmid (m) | sc-420769-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMα Double Nickase Plasmid (m) | sc-420769-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMα Double Nickase Plasmid (m2) | sc-420769-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ CRISPR/Cas9 KO Plasmid (h) | sc-406436 | h | Gene Knockout | GFP | 0 | ||
HLA-DMβ HDR Plasmid (h2) | sc-406436-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMβ Double Nickase Plasmid (h) | sc-406436-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ Double Nickase Plasmid (h2) | sc-406436-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ CRISPR/Cas9 KO Plasmid (m) | sc-420770 | m | Gene Knockout | GFP | 0 | ||
HLA-DMβ HDR Plasmid (m) | sc-420770-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMβ Double Nickase Plasmid (m) | sc-420770-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ Double Nickase Plasmid (m2) | sc-420770-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOα CRISPR/Cas9 KO Plasmid (h) | sc-410820 | h | Gene Knockout | GFP | 0 | ||
HLA-DOα HDR Plasmid (h) | sc-410820-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOα Double Nickase Plasmid (h) | sc-410820-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOα Double Nickase Plasmid (h2) | sc-410820-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOα CRISPR/Cas9 KO Plasmid (m) | sc-420772 | m | Gene Knockout | GFP | 0 | ||
HLA-DOα HDR Plasmid (m) | sc-420772-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOα Double Nickase Plasmid (m) | sc-420772-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOα Double Nickase Plasmid (m2) | sc-420772-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ CRISPR/Cas9 KO Plasmid (h) | sc-406402 | h | Gene Knockout | GFP | 0 | ||
HLA-DOβ HDR Plasmid (h) | sc-406402-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOβ Double Nickase Plasmid (h) | sc-406402-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ Double Nickase Plasmid (h2) | sc-406402-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ CRISPR/Cas9 KO Plasmid (m) | sc-420773 | m | Gene Knockout | GFP | 0 | ||
HLA-DOβ HDR Plasmid (m) | sc-420773-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DOβ Double Nickase Plasmid (m) | sc-420773-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DOβ Double Nickase Plasmid (m2) | sc-420773-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DRα CRISPR/Cas9 KO Plasmid (h2) | sc-401010-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DRα HDR Plasmid (h2) | sc-401010-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRα Double Nickase Plasmid (h) | sc-401010-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRα Double Nickase Plasmid (h2) | sc-401010-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-E CRISPR/Cas9 KO Plasmid (h2) | sc-403124-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-E HDR Plasmid (h2) | sc-403124-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-E Double Nickase Plasmid (h) | sc-403124-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-E Double Nickase Plasmid (h2) | sc-403124-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-E CRISPR/Cas9 KO Plasmid (m) | sc-437133 | m | Gene Knockout | GFP | 0 | ||
HLA-E HDR Plasmid (m) | sc-437133-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-E Double Nickase Plasmid (m) | sc-437133-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-E Double Nickase Plasmid (m2) | sc-437133-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-F CRISPR/Cas9 KO Plasmid (h) | sc-410821 | h | Gene Knockout | GFP | 0 | ||
HLA-F Double Nickase Plasmid (h) | sc-410821-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-F Double Nickase Plasmid (h2) | sc-410821-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-G CRISPR/Cas9 KO Plasmid (h2) | sc-401226-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-G HDR Plasmid (h2) | sc-401226-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-G Double Nickase Plasmid (h) | sc-401226-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-G Double Nickase Plasmid (h2) | sc-401226-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-G CRISPR/Cas9 KO Plasmid (m) | sc-420761 | m | Gene Knockout | GFP | 0 | ||
HLA-G HDR Plasmid (m) | sc-420761-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-G Double Nickase Plasmid (m) | sc-420761-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-G Double Nickase Plasmid (m2) | sc-420761-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 CRISPR/Cas9 KO Plasmid (h) | sc-401413 | h | Gene Knockout | GFP | 0 | ||
HLA-DP β1 HDR Plasmid (h) | sc-401413-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DP β1 Double Nickase Plasmid (h) | sc-401413-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DP β1 Double Nickase Plasmid (h2) | sc-401413-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DPα1 CRISPR/Cas9 KO Plasmid (h) | sc-417402 | h | Gene Knockout | GFP | 0 | ||
HLA-DPα1 HDR Plasmid (h) | sc-417402-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DPα1 Double Nickase Plasmid (h) | sc-417402-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DPα1 Double Nickase Plasmid (h2) | sc-417402-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 CRISPR/Cas9 KO Plasmid (h) | sc-403480 | h | Gene Knockout | GFP | 0 | ||
HLA-DQA1 HDR Plasmid (h) | sc-403480-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQA1 Double Nickase Plasmid (h) | sc-403480-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA1 Double Nickase Plasmid (h2) | sc-403480-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 CRISPR/Cas9 KO Plasmid (h2) | sc-403051-KO-2 | h | Gene Knockout | GFP | 0 | ||
HLA-DQB1 Double Nickase Plasmid (h) | sc-403051-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB1 Double Nickase Plasmid (h2) | sc-403051-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 CRISPR/Cas9 KO Plasmid (h) | sc-406727 | h | Gene Knockout | GFP | 0 | ||
HLA-DRβ1 CRISPR/Cas9 KO Plasmid (h2) | sc-406727-KO-2 | h2 | Gene Knockout | GFP | 0 | ||
HLA-DRβ1 HDR Plasmid (h2) | sc-406727-HDR-2 | h2 | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRβ1 Double Nickase Plasmid (h) | sc-406727-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ1 Double Nickase Plasmid (h2) | sc-406727-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-HB1 CRISPR/Cas9 KO Plasmid (h) | sc-412897 | h | Gene Knockout | GFP | 0 | ||
HLA-HB1 HDR Plasmid (h) | sc-412897-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-HB1 Double Nickase Plasmid (h) | sc-412897-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-HB1 Double Nickase Plasmid (h2) | sc-412897-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ2 CRISPR/Cas9 KO Plasmid (m) | sc-420771 | m | Gene Knockout | GFP | 0 | ||
HLA-DMβ2 HDR Plasmid (m) | sc-420771-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
HLA-DMβ2 Double Nickase Plasmid (m) | sc-420771-NIC | m | Gene Knockout | Puromycin | 0 | ||
HLA-DMβ2 Double Nickase Plasmid (m2) | sc-420771-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
HLA-DQA2 CRISPR/Cas9 KO Plasmid (h) | sc-408740 | h | Gene Knockout | GFP | 0 | ||
HLA-DQA2 HDR Plasmid (h) | sc-408740-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQA2 Double Nickase Plasmid (h) | sc-408740-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQA2 Double Nickase Plasmid (h2) | sc-408740-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB2 CRISPR/Cas9 KO Plasmid (h) | sc-418865 | h | Gene Knockout | GFP | 0 | ||
HLA-DQB2 HDR Plasmid (h) | sc-418865-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DQB2 Double Nickase Plasmid (h) | sc-418865-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DQB2 Double Nickase Plasmid (h2) | sc-418865-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 CRISPR/Cas9 KO Plasmid (h) | sc-402985 | h | Gene Knockout | GFP | 0 | ||
HLA-DRβ5 HDR Plasmid (h) | sc-402985-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
HLA-DRβ5 Double Nickase Plasmid (h) | sc-402985-NIC | h | Gene Knockout | Puromycin | 0 | ||
HLA-DRβ5 Double Nickase Plasmid (h2) | sc-402985-NIC-2 | h | Gene Knockout | Puromycin | 0 |
HLA CRISPR Activation Products
Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
---|---|---|---|---|---|---|---|
HLA-A CRISPR Activation Plasmid (h) | sc-400294-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-A CRISPR Activation Plasmid (h2) | sc-400294-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-A Lentiviral Activation Particles (h) | sc-400294-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-A Lentiviral Activation Particles (h2) | sc-400294-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-B CRISPR Activation Plasmid (h) | sc-400627-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-B CRISPR Activation Plasmid (h2) | sc-400627-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-B Lentiviral Activation Particles (h) | sc-400627-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-B Lentiviral Activation Particles (h2) | sc-400627-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-C CRISPR Activation Plasmid (h) | sc-401517-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-C CRISPR Activation Plasmid (h2) | sc-401517-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-C Lentiviral Activation Particles (h) | sc-401517-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-C Lentiviral Activation Particles (h2) | sc-401517-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα CRISPR Activation Plasmid (h) | sc-404576-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα CRISPR Activation Plasmid (h2) | sc-404576-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα Lentiviral Activation Particles (h) | sc-404576-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα Lentiviral Activation Particles (h2) | sc-404576-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα CRISPR Activation Plasmid (m) | sc-420769-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα CRISPR Activation Plasmid (m2) | sc-420769-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα Lentiviral Activation Particles (m) | sc-420769-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMα Lentiviral Activation Particles (m2) | sc-420769-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ CRISPR Activation Plasmid (h) | sc-406436-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ CRISPR Activation Plasmid (h2) | sc-406436-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ Lentiviral Activation Particles (h) | sc-406436-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ Lentiviral Activation Particles (h2) | sc-406436-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ CRISPR Activation Plasmid (m) | sc-420770-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ CRISPR Activation Plasmid (m2) | sc-420770-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ Lentiviral Activation Particles (m) | sc-420770-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ Lentiviral Activation Particles (m2) | sc-420770-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα CRISPR Activation Plasmid (h) | sc-410820-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα CRISPR Activation Plasmid (h2) | sc-410820-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα Lentiviral Activation Particles (h) | sc-410820-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα Lentiviral Activation Particles (h2) | sc-410820-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα CRISPR Activation Plasmid (m) | sc-420772-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα CRISPR Activation Plasmid (m2) | sc-420772-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα Lentiviral Activation Particles (m) | sc-420772-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOα Lentiviral Activation Particles (m2) | sc-420772-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ CRISPR Activation Plasmid (h) | sc-406402-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ CRISPR Activation Plasmid (h2) | sc-406402-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ Lentiviral Activation Particles (h) | sc-406402-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ Lentiviral Activation Particles (h2) | sc-406402-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ CRISPR Activation Plasmid (m) | sc-420773-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ CRISPR Activation Plasmid (m2) | sc-420773-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ Lentiviral Activation Particles (m) | sc-420773-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DOβ Lentiviral Activation Particles (m2) | sc-420773-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα CRISPR Activation Plasmid (h) | sc-401010-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα CRISPR Activation Plasmid (h2) | sc-401010-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα Lentiviral Activation Particles (h) | sc-401010-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRα Lentiviral Activation Particles (h2) | sc-401010-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activation Plasmid (h) | sc-403124-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activation Plasmid (h2) | sc-403124-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E Lentiviral Activation Particles (h) | sc-403124-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E Lentiviral Activation Particles (h2) | sc-403124-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activation Plasmid (m) | sc-437133-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E CRISPR Activation Plasmid (m2) | sc-437133-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E Lentiviral Activation Particles (m) | sc-437133-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-E Lentiviral Activation Particles (m2) | sc-437133-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-F CRISPR Activation Plasmid (h) | sc-410821-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-F CRISPR Activation Plasmid (h2) | sc-410821-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-F Lentiviral Activation Particles (h) | sc-410821-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-F Lentiviral Activation Particles (h2) | sc-410821-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G CRISPR Activation Plasmid (h) | sc-401226-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G CRISPR Activation Plasmid (h2) | sc-401226-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G Lentiviral Activation Particles (h) | sc-401226-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G Lentiviral Activation Particles (h2) | sc-401226-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G CRISPR Activation Plasmid (m) | sc-420761-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G CRISPR Activation Plasmid (m2) | sc-420761-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G Lentiviral Activation Particles (m) | sc-420761-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-G Lentiviral Activation Particles (m2) | sc-420761-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 CRISPR Activation Plasmid (h) | sc-401413-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 CRISPR Activation Plasmid (h2) | sc-401413-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 Lentiviral Activation Particles (h) | sc-401413-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DP β1 Lentiviral Activation Particles (h2) | sc-401413-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DPα1 CRISPR Activation Plasmid (h) | sc-417402-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DPα1 CRISPR Activation Plasmid (h2) | sc-417402-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DPα1 Lentiviral Activation Particles (h) | sc-417402-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DPα1 Lentiviral Activation Particles (h2) | sc-417402-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA1 CRISPR Activation Plasmid (h) | sc-403480-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA1 CRISPR Activation Plasmid (h2) | sc-403480-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA1 Lentiviral Activation Particles (h) | sc-403480-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA1 Lentiviral Activation Particles (h2) | sc-403480-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB1 CRISPR Activation Plasmid (h) | sc-403051-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB1 CRISPR Activation Plasmid (h2) | sc-403051-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB1 Lentiviral Activation Particles (h) | sc-403051-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB1 Lentiviral Activation Particles (h2) | sc-403051-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 CRISPR Activation Plasmid (h) | sc-406727-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 CRISPR Activation Plasmid (h2) | sc-406727-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 Lentiviral Activation Particles (h) | sc-406727-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ1 Lentiviral Activation Particles (h2) | sc-406727-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-HB1 CRISPR Activation Plasmid (h) | sc-412897-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-HB1 CRISPR Activation Plasmid (h2) | sc-412897-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-HB1 Lentiviral Activation Particles (h) | sc-412897-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-HB1 Lentiviral Activation Particles (h2) | sc-412897-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ2 CRISPR Activation Plasmid (m) | sc-420771-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ2 CRISPR Activation Plasmid (m2) | sc-420771-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ2 Lentiviral Activation Particles (m) | sc-420771-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DMβ2 Lentiviral Activation Particles (m2) | sc-420771-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA2 CRISPR Activation Plasmid (h) | sc-408740-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA2 CRISPR Activation Plasmid (h2) | sc-408740-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA2 Lentiviral Activation Particles (h) | sc-408740-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQA2 Lentiviral Activation Particles (h2) | sc-408740-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB2 CRISPR Activation Plasmid (h) | sc-418865-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB2 CRISPR Activation Plasmid (h2) | sc-418865-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB2 Lentiviral Activation Particles (h) | sc-418865-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DQB2 Lentiviral Activation Particles (h2) | sc-418865-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ5 CRISPR Activation Plasmid (h) | sc-402985-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ5 CRISPR Activation Plasmid (h2) | sc-402985-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ5 Lentiviral Activation Particles (h) | sc-402985-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
HLA-DRβ5 Lentiviral Activation Particles (h2) | sc-402985-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
HLA siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
---|---|---|---|---|---|---|---|
HLA-A siRNA (h) | sc-42908 | h | Gene Silencing | N/A | 0 | ||
HLA-A shRNA Plasmid (h) | sc-42908-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-A shRNA (h) Lentiviral Particles | sc-42908-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-B siRNA (h) | sc-42922 | h | Gene Silencing | N/A | 0 | ||
HLA-B shRNA Plasmid (h) | sc-42922-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-B shRNA (h) Lentiviral Particles | sc-42922-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-C siRNA (h) | sc-105525 | h | Gene Silencing | N/A | 0 | ||
HLA-C shRNA Plasmid (h) | sc-105525-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-C shRNA (h) Lentiviral Particles | sc-105525-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα siRNA (h) | sc-42909 | h | Gene Silencing | N/A | 0 | ||
HLA-DMα shRNA Plasmid (h) | sc-42909-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα shRNA (h) Lentiviral Particles | sc-42909-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMα siRNA (m) | sc-42910 | m | Gene Silencing | N/A | 0 | ||
HLA-DMα shRNA Plasmid (m) | sc-42910-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DMα shRNA (m) Lentiviral Particles | sc-42910-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DM&beta shRNA Plasmid (m) | sc-42912-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DM&beta shRNA (m) Lentiviral Particles | sc-42912-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ siRNA (h) | sc-42911 | h | Gene Silencing | N/A | 0 | ||
HLA-DMβ shRNA Plasmid (h) | sc-42911-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ shRNA (h) Lentiviral Particles | sc-42911-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DMβ siRNA (m) | sc-42912 | m | Gene Silencing | N/A | 0 | ||
HLA-DOα siRNA (h) | sc-95165 | h | Gene Silencing | N/A | 0 | ||
HLA-DOα shRNA Plasmid (h) | sc-95165-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOα shRNA (h) Lentiviral Particles | sc-95165-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOα siRNA (m) | sc-105526 | m | Gene Silencing | N/A | 0 | ||
HLA-DOα shRNA Plasmid (m) | sc-105526-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOα shRNA (m) Lentiviral Particles | sc-105526-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ siRNA (h) | sc-42913 | h | Gene Silencing | N/A | 0 | ||
HLA-DOβ shRNA Plasmid (h) | sc-42913-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ shRNA (h) Lentiviral Particles | sc-42913-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ siRNA (m) | sc-42914 | m | Gene Silencing | N/A | 0 | ||
HLA-DOβ shRNA Plasmid (m) | sc-42914-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DOβ shRNA (m) Lentiviral Particles | sc-42914-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DRα siRNA (h) | sc-37113 | h | Gene Silencing | N/A | 4 | ||
HLA-DRα shRNA Plasmid (h) | sc-37113-SH | h | Gene Silencing | Puromycin | 4 | ||
HLA-DRα shRNA (h) Lentiviral Particles | sc-37113-V | h | Gene Silencing | Puromycin | 4 | ||
HLA-DRα siRNA (m) | sc-37114 | m | Gene Silencing | N/A | 0 | ||
HLA-DRα shRNA Plasmid (m) | sc-37114-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-DRα shRNA (m) Lentiviral Particles | sc-37114-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-E siRNA (h) | sc-62470 | h | Gene Silencing | N/A | 1 | ||
HLA-E shRNA Plasmid (h) | sc-62470-SH | h | Gene Silencing | Puromycin | 1 | ||
HLA-E shRNA (h) Lentiviral Particles | sc-62470-V | h | Gene Silencing | Puromycin | 1 | ||
HLA-E siRNA (m) | sc-62471 | m | Gene Silencing | N/A | 0 | ||
HLA-E shRNA Plasmid (m) | sc-62471-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-E shRNA (m) Lentiviral Particles | sc-62471-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-F siRNA (h) | sc-105528 | h | Gene Silencing | N/A | 0 | ||
HLA-F shRNA Plasmid (h) | sc-105528-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-F shRNA (h) Lentiviral Particles | sc-105528-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-G siRNA (h) | sc-42920 | h | Gene Silencing | N/A | 2 | ||
HLA-G shRNA Plasmid (h) | sc-42920-SH | h | Gene Silencing | Puromycin | 2 | ||
HLA-G shRNA (h) Lentiviral Particles | sc-42920-V | h | Gene Silencing | Puromycin | 2 | ||
HLA-G siRNA (m) | sc-42921 | m | Gene Silencing | N/A | 0 | ||
HLA-G shRNA Plasmid (m) | sc-42921-SH | m | Gene Silencing | Puromycin | 0 | ||
HLA-G shRNA (m) Lentiviral Particles | sc-42921-V | m | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 siRNA (h) | sc-43929 | h | Gene Silencing | N/A | 0 | ||
HLA-DP β1 siRNA (h) | sc-42915 | h | Gene Silencing | N/A | 0 | ||
HLA-DP β1 shRNA Plasmid (h) | sc-42915-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 shRNA Plasmid (h) | sc-43929-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 shRNA (h) Lentiviral Particles | sc-42915-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DP β1 shRNA (h) Lentiviral Particles | sc-43929-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DPα1 siRNA (h) | sc-95353 | h | Gene Silencing | N/A | 0 | ||
HLA-DPα1 shRNA Plasmid (h) | sc-95353-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DPα1 shRNA (h) Lentiviral Particles | sc-95353-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA1 siRNA (h) | sc-105527 | h | Gene Silencing | N/A | 0 | ||
HLA-DQA1 shRNA Plasmid (h) | sc-105527-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA1 shRNA (h) Lentiviral Particles | sc-105527-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQB1 siRNA (h) | sc-42918 | h | Gene Silencing | N/A | 0 | ||
HLA-DQB1 shRNA Plasmid (h) | sc-42918-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQB1 shRNA (h) Lentiviral Particles | sc-42918-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-HB1 siRNA (h) | sc-91802 | h | Gene Silencing | N/A | 0 | ||
HLA-HB1 shRNA Plasmid (h) | sc-91802-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-HB1 shRNA (h) Lentiviral Particles | sc-91802-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA2 siRNA (h) | sc-42917 | h | Gene Silencing | N/A | 0 | ||
HLA-DQA2 shRNA Plasmid (h) | sc-42917-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DQA2 shRNA (h) Lentiviral Particles | sc-42917-V | h | Gene Silencing | Puromycin | 0 | ||
HLA-DRβ5 siRNA (h) | sc-72095 | h | Gene Silencing | N/A | 0 | ||
HLA-DRβ5 shRNA Plasmid (h) | sc-72095-SH | h | Gene Silencing | Puromycin | 0 | ||
HLA-DRβ5 shRNA (h) Lentiviral Particles | sc-72095-V | h | Gene Silencing | Puromycin | 0 |
HLA Transfected Lysates
Empty Table Header | Product Name | CATALOG # | Species | CONTROL ANTIBODY | Citations | RATING |
---|---|---|---|---|---|---|
HLA-G (h2): 293T Lysate | sc-159524 | h2 | 0 |